Fresenius SE & Co. KGaA (FRE.DE)
EUR 34.19
(0.41%)
EUR 34.19
(0.41%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -1.05 EUR | -143.03% |
| 2022 | 2.44 EUR | -25.15% |
| 2021 | 3.26 EUR | 6.54% |
| 2020 | 3.06 EUR | -9.47% |
| 2019 | 3.38 EUR | -7.14% |
| 2018 | 3.64 EUR | 11.66% |
| 2017 | 3.26 EUR | 14.79% |
| 2016 | 2.84 EUR | 13.6% |
| 2015 | 2.50 EUR | 26.9% |
| 2014 | 1.97 EUR | 4.23% |
| 2013 | 1.89 EUR | 6.18% |
| 2012 | 1.78 EUR | 26.24% |
| 2011 | 1.41 EUR | 10.16% |
| 2010 | 1.28 EUR | 25.49% |
| 2009 | 1.02 EUR | 78.95% |
| 2008 | 0.57 EUR | -35.23% |
| 2007 | 0.88 EUR | 22.22% |
| 2006 | 0.72 EUR | 22.03% |
| 2005 | 0.59 EUR | -56.62% |
| 2004 | 1.36 EUR | 46.24% |
| 2003 | 0.93 EUR | -13.89% |
| 2002 | 1.08 EUR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.66 EUR | -234.69% |
| 2024 Q1 | 0.49 EUR | 144.95% |
| 2023 Q4 | -1.09 EUR | -49.32% |
| 2023 FY | - EUR | -143.03% |
| 2023 Q1 | 0.62 EUR | 34.78% |
| 2023 Q2 | 0.14 EUR | -77.42% |
| 2023 Q3 | -0.73 EUR | -621.43% |
| 2022 Q3 | 0.58 EUR | -14.71% |
| 2022 Q4 | 0.46 EUR | -20.69% |
| 2022 FY | - EUR | -25.15% |
| 2022 Q1 | 0.75 EUR | -15.73% |
| 2022 Q2 | 0.68 EUR | -9.33% |
| 2021 Q4 | 0.89 EUR | 20.27% |
| 2021 Q2 | 0.84 EUR | 7.69% |
| 2021 Q1 | 0.78 EUR | 5.41% |
| 2021 Q3 | 0.74 EUR | -11.9% |
| 2021 FY | - EUR | 6.54% |
| 2020 Q4 | 0.74 EUR | -3.9% |
| 2020 Q1 | 0.82 EUR | -11.83% |
| 2020 Q2 | 0.74 EUR | -9.76% |
| 2020 Q3 | 0.77 EUR | 4.05% |
| 2020 FY | - EUR | -9.47% |
| 2019 FY | - EUR | -7.14% |
| 2019 Q1 | 0.81 EUR | -11.96% |
| 2019 Q4 | 0.93 EUR | 16.25% |
| 2019 Q3 | 0.80 EUR | -5.88% |
| 2019 Q2 | 0.85 EUR | 4.94% |
| 2018 Q3 | 0.75 EUR | -36.44% |
| 2018 Q4 | 0.92 EUR | 22.67% |
| 2018 FY | - EUR | 11.66% |
| 2018 Q1 | 0.79 EUR | -14.13% |
| 2018 Q2 | 1.18 EUR | 49.37% |
| 2017 Q1 | 0.83 EUR | 3.75% |
| 2017 Q4 | 0.92 EUR | 29.58% |
| 2017 Q3 | 0.71 EUR | -12.35% |
| 2017 FY | - EUR | 14.79% |
| 2017 Q2 | 0.81 EUR | -2.41% |
| 2016 Q4 | 0.80 EUR | 15.94% |
| 2016 Q2 | 0.70 EUR | 7.69% |
| 2016 Q1 | 0.65 EUR | -1.52% |
| 2016 FY | - EUR | 13.6% |
| 2016 Q3 | 0.69 EUR | -1.43% |
| 2015 Q1 | 0.58 EUR | 23.4% |
| 2015 FY | - EUR | 26.9% |
| 2015 Q4 | 0.66 EUR | 0.0% |
| 2015 Q3 | 0.66 EUR | 10.0% |
| 2015 Q2 | 0.60 EUR | 3.45% |
| 2014 FY | - EUR | 4.23% |
| 2014 Q2 | 0.53 EUR | 15.22% |
| 2014 Q3 | 0.51 EUR | -3.77% |
| 2014 Q4 | 0.47 EUR | -7.84% |
| 2014 Q1 | 0.46 EUR | -13.21% |
| 2013 Q2 | 0.45 EUR | 9.76% |
| 2013 Q3 | 0.50 EUR | 11.11% |
| 2013 Q4 | 0.53 EUR | 6.0% |
| 2013 FY | - EUR | 6.18% |
| 2013 Q1 | 0.41 EUR | -8.89% |
| 2012 Q4 | 0.45 EUR | -2.17% |
| 2012 FY | - EUR | 26.24% |
| 2012 Q2 | 0.78 EUR | -16.13% |
| 2012 Q1 | 0.93 EUR | 14.81% |
| 2012 Q3 | 0.46 EUR | -41.03% |
| 2011 Q3 | 0.80 EUR | 42.86% |
| 2011 Q4 | 0.81 EUR | 1.25% |
| 2011 FY | - EUR | 10.16% |
| 2011 Q2 | 0.56 EUR | 3.7% |
| 2011 Q1 | 0.54 EUR | -25.0% |
| 2010 FY | - EUR | 25.49% |
| 2010 Q4 | 0.72 EUR | 1.41% |
| 2010 Q2 | 0.62 EUR | 44.19% |
| 2010 Q1 | 0.43 EUR | -29.51% |
| 2010 Q3 | 0.71 EUR | 14.52% |
| 2009 Q3 | 0.39 EUR | -20.41% |
| 2009 Q2 | 0.49 EUR | -15.52% |
| 2009 Q1 | 0.58 EUR | 0.0% |
| 2009 FY | - EUR | 78.95% |
| 2009 Q4 | 0.61 EUR | 56.41% |
| 2008 FY | - EUR | -35.23% |
| 2007 FY | - EUR | 22.22% |
| 2006 FY | - EUR | 22.03% |
| 2005 FY | - EUR | -56.62% |
| 2004 FY | - EUR | 46.24% |
| 2003 FY | - EUR | -13.89% |
| 2002 FY | - EUR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Fresenius Medical Care AG & Co. KGaA | 1.70 EUR | 161.765% |
| LIMES Schlosskliniken AG | 11.58 EUR | 109.067% |
| M1 Kliniken AG | 0.54 EUR | 294.444% |
| Maternus-Kliniken Aktiengesellschaft | -0.68 EUR | -54.412% |
| MEDICLIN Aktiengesellschaft | -0.23 EUR | -356.522% |
| RHÖN-KLINIKUM Aktiengesellschaft | 0.58 EUR | 281.034% |
| VITA 34 AG | -0.12 EUR | -775.0% |